Primary thrombectomy within 3 hours of onset in acute ischemic stroke from occlusion of middle cerebral artery- a pilot study. Y.Lodi 1,2,3, V.V Reddy 2, A Devasenapathy 2, K.S Shehadeh 3, A Hourani 3 C-A.Chou 3 1 Department of Neurology, Neurosurgery and Radiology, SUNY Upstate Medical University Binghamton Clinical Campus, NY, 2 UHS-Wilson Regional Medical Center, NY, 3 SSIE Department at Binghamton University, NY Contact Information: Yahia M Lodi, MD., FAHA., FANA. Neurosciences Academic Chair Professor (Tenured) of Neurology, Neurosurgery & Radiology Upstate Medical University, Syracuse, NY-Binghamton Campus Visiting Professor, Thomas Watson School of Engineering, Binghamton University, NY Executive Director Comprehensive Stroke/Neurocriticalcare and Neuroendovascular Program Fellowship Director, NeurocriticalCare Program at UHS-WMC Fellowship Director, Endovascular Surgical Neuroradiology at UHS-WMC UHS-Wilson Regional Medical Center
Disclosure Nothing to disclose
Backgrounds 1.9 million cells die each minute in acute ischemic stroke (AIS); delay in recanalization means more cell death and poor outcome AIS with high NIHSS (>10), due to large artery occlusion (LAO), especially in internal carotid artery terminus (ICA-T) are resistant to IV thrombolysis and thrombectomy is associated with better recanalization rates. IV thrombolysis with large clot burden (>8mm) (LCB) in the middle cerebral artery (MCA) is associated with poor recanalization and outcome. Thrombectomy in AIS with LAO within 3 hours is performed as secondary therapy after IV thrombolysis which may lead to delay in recanalization and may not guarantee a good outcome
Objectives To evaluate the safety, feasibility and recanalization rate of primary thrombectomy within 3 hours in AIS with NIHSS >10 from occlusion of MCA with LCB. Additionally, we like to report the functional outcome
Methods Based on institutionally approved protocol patients with LAO (ICA-T, MCA, vertebralbasilar artery) with LCB within 3 hours were offered primary stent retriever thrombectomy (SRT) as an alternative to IV rtpa, after informed consent. Prospectively maintained stroke database, consecutive patients who underwent primary MCA SRT within 3 hours from 2012 to 2014 were analyzed using SAS software. Outcomes were measured using modified Rankin Scale (mrs)
Procedure We kept the procedure very simple Selected patient received 300 mg to 600 mg rectal aspirin Blood pressure kept between SBP140-180 mm Hg Conscious sedation 8F balloon guide, microcatheter and stent retriever device Post procedure SBP 120-160 mm Hg Aspirin and plavix If no hemorrhage in 24 hours CT head
Results 10 patients with MCA occlusion; mean age 65±15.87 years and mean NIHSS 16±5; chose primary SRT after informed consent. Thrombectomy was performed using new generation stent-retriever device in addition to intra-arterial rtpa (2-4 mg). Number of passes was 1.4±.7. Near complete (TICI2b1) and complete (TICI3 9) recanalization was observed in all (100%) patients. Mean time to recanalization from symptoms onset was 160±37 minutes.
Results Immediate post-thrombectomy, 24 hour and 30 day NIHSS score was 2.6±1.4, 1.9±3.7 and 0 respectively. There was no procedure related complication. Asymptomatic perfusion related hemorrhage developed in 3 patients (33%). 30 day good outcome was observed in all cases (mrs0= 30%, mrs1=50%, mrs2=20%)
Figure 1: Before and after primary SRT
Figure 2: After primary SRT; clot in the stent retriever device
Figure 3: Before and after primary SRT: Right MCA occlusion with NIHSS 19
Figure 4: Clot in the stent retriever device after primary SRT
Conclusion Our pilot study demonstrates that primary SRT in AIS due to MCA occlusion with LCB is not only safe and feasible, but associated with complete recanalization and good functional outcome.
Future studies Primary Acute Stroke thrombectomy In 3 Hours (PAST3) A Pilot Trial We will compare PAST3 with those either IV rtpa or IV rtpa followed by thrombectomy Larger randomized controlled studies are needed.
References Zaidat O1, Castonguay A1, Veznedaroglu E2, Binning M2, Alshekhlee A3, Abraham M4, Mehta S5, El Khoury R6, Majjhoo A7, Lin E8, Kabbani M9, Froehler M10, Nguyen T11.P-021 TREVO Stent-Retriever Acute Stroke (TRACK) Postmarketing Registry: Interim Revascularization and Clinical Outcome Results Compared to TREVO-2 and NASA Registry. J Neurointerv Surg. 2014 Jul;6 Suppl 1:A31-2. doi: 10.1136/neurintsurg-2014-011343.57. Shi ZS1, Liebeskind DS2, Xiang B2, Ge SG2, Feng L2, Albers GW2, Budzik R2, Devlin T2, Gupta R2, Jansen O2, Jovin TG2, Killer-Oberpfalzer M2, Lutsep HL2, Macho J2, Nogueira RG2, Rymer M2, Smith WS2, Wahlgren N2, Duckwiler GR2; Multi MERCI, TREVO, and TREVO 2 Investigators.Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes. Stroke. 2014 Jul;45(7):1977-84. doi: 10.1161/STROKEAHA.114.005603. Epub 2014 May 29. Villwock MR1, Singla A, Padalino DJ, Deshaies EM. Acute ischaemic stroke outcomes following mechanical thrombectomy in the elderly versus their younger counterpart: a retrospective cohort study. BMJ Open. 2014 Mar 20;4(3):e004480. doi: 10.1136/bmjopen-2013-004480. Zaidat OO1, Castonguay AC2, Gupta R3, Sun CH3, Martin C4, Holloway WE4, Mueller-Kronast N5, English JD6, Linfante I7, Dabus G7, Malisch TW8, Marden FA8, Bozorgchami H9, Xavier A10, Rai AT11, Froehler MT12, Badruddin A13, Nguyen TN14, Taqi MA15, Abraham MG16, Janardhan V17, Shaltoni H18, Novakovic R19, Yoo AJ20, Abou-Chebl A21, Chen PR22, Britz GW23, Kaushal R24, Nanda A25, Issa MA2, Nogueira RG3. North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results. J Neurointerv Surg. 2014 Oct;6(8):584-8. doi: 10.1136/neurintsurg-2013-010895. Epub 2013 Sep 23. Cohen JE1, Leker RR. Revascularization-outcome paradox: not only time and collaterals status, but also complete recanalization contribute to good neurological outcome. Int J Stroke. 2013 Oct;8(7):542-4. doi: 10.1111/ijs.12165.